Background: Impaired vascular compliance is associated with cardiovascular mortality. The effects of heart rate on vascular compliance are unclear. Therefore, we characterized effects of heart rate reduction (HRR) by I(f) current inhibition on aortic compliance and underlying molecular mechanisms in apolipoprotein E-deficient (ApoE–/–) mice. Methods: ApoE–/– mice fed a high-cholesterol diet and wild-type (WT) mice were treated with ivabradine (20 mg/kg/d) or vehicle for 6 weeks. Compliance of the ascending aorta was evaluated by MRI. Results: Ivabradine reduced heart rate by 113 ± 31 bpm (∼19%) in WT mice and by 133 ± 6 bpm (∼23%) in ApoE–/– mice. Compared to WT controls, ApoE–/– mice exhibited reduced distensibility and circumferential strain. HRR by ivabradine increased distensibility and circumferential strain in ApoE–/– mice but did not affect both parameters in WT mice. Ivabradine reduced aortic protein and mRNA expression of the angiotensin II type 1 (AT1) receptor and reduced rac1-GTPase activity in ApoE–/– mice. Moreover, membrane translocation of p47phox was inhibited. In ApoE–/– mice, HRR induced anti-inflammatory effects by reduction of aortic mRNA expression of IL-6, TNF-alpha and TGF-beta. Conclusion: HRR by ivabradine improves vascular compliance in ApoE–/– mice. Contributing mechanisms include downregulation of the AT1 receptor, attenuation of oxidative stress and modulation of inflammatory cytokine expression.

Keywords:
Apolipoprotein E knockout mice, Heart rate reduction, Ivabradine, Aortic compliance
1.
Custodis F, Schirmer SH, Baumhäkel M, Heusch G, Böhm M, Laufs U: Vascular pathophysiology in response to increased heart rate. J Am Coll Cardiol 2010;56:1973–1983.
2.
Custodis F, Baumhäkel M, Schlimmer N, List F, Gensch C, Böhm M, Laufs U: Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice. Circulation 2008;117:2377–2387.
3.
Drouin A, Gendron ME, Thorin E, Gillis MA, Mahlberg-Gaudin F, Tardif JC: Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice. Br J Pharmacol 2008;154:749–757.
4.
Baumhäkel M, Custodis F, Schlimmer N, Laufs U, Böhm M: Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. Atherosclerosis 2010;212:55–62.
5.
Custodis F, Gertz K, Balkaya M, Prinz V, Mathar I, Stamm C, Kronenberg G, Kazakov A, Freichel M, Böhm M, Endres M, Laufs U: Heart rate contributes to the vascular effects of chronic mental stress: effects on endothelial function and ischemic brain injury in mice. Stroke 2011;42:1742–1749.
6.
O’Rourke MF, Hashimoto J: Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007;50:1–13.
7.
Cavalcante JL, Lima JA, Redheuil A, Al-Mallah MH: Aortic stiffness: current understanding and future directions. J Am Coll Cardiol 2011;57:1511–1522.
8.
Lacolley P, Safar ME, Regnault V, Frohlich ED: Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension. Am J Physiol Heart Circ Physiol 2009;297:H1567–1575.
9.
Zieman SJ, Melenovsky V, Kass DA: Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005;25:932–943.
10.
Bassiouny HS, Zarins CK, Kadowaki MH, Glagov S: Hemodynamic stress and experimental aortoiliac atherosclerosis. J Vasc Surg 1994;19:426–434.
11.
Giannattasio C, Vincenti A, Failla M, Capra A, Ciro A, De Ceglia S, Gentile G, Brambilla R, Mancia G: Effects of heart rate changes on arterial distensibility in humans. Hypertension 2003;42:253–256.
12.
Mircoli L, Mangoni AA, Giannattasio C, Mancia G, Ferrari AU: Heart rate-dependent stiffening of large arteries in intact and sympathectomized rats. Hypertension 1999;34:598–602.
13.
Sa Cunha R, Pannier B, Benetos A, Siche JP, London GM, Mallion JM, Safar ME: Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997;15:1423–1430.
14.
Hartley CJ, Reddy AK, Madala S, Martin-McNulty B, Vergona R, Sullivan ME, Halks-Miller M, Taffet GE, Michael LH, Entman ML, Wang YX: Hemodynamic changes in apolipoprotein E-knockout mice. Am J Physiol Heart Circ Physiol 2000;279:H2326–2334.
15.
Du XJ, Feng X, Gao XM, Tan TP, Kiriazis H, Dart AM: I(f) channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities. Br J Pharmacol 2004;142:107–112.
16.
Hundley WG, Kitzman DW, Morgan TM, Hamilton CA, Darty SN, Stewart KP, Herrington DM, Link KM, Little WC: Cardiac cycle-dependent changes in aortic area and distensibility are reduced in older patients with isolated diastolic heart failure and correlate with exercise intolerance. J Am Coll Cardiol 2001;38:796–802.
17.
Morrison TM, Choi G, Zarins CK, Taylor CA: Circumferential and longitudinal cyclic strain of the human thoracic aorta: age-related changes. J Vasc Surg 2009;49:1029–1036.
18.
Custodis F, Eberl M, Kilter H, Böhm M, Laufs U: Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy. Cardiovasc Res 2006;71:342–351.
19.
Libby P: Inflammation in atherosclerosis. Nature 2002;420:868–874.
20.
Schirmer SH, Degen A, Baumhäkel M, Custodis F, Schuh L, Kohlhaas M, Friedrich E, Bahlmann F, Kappl R, Maack C, Böhm M, Laufs U: Heart-rate reduction by I(f)-channel inhibition with ivabradine restores collateral artery growth in hypercholesterolemic atherosclerosis. Eur Heart J 2012;33:1223–1231.
21.
McEniery CM, Spratt M, Munnery M, Yarnell J, Lowe GD, Rumley A, Gallacher J, Ben-Shlomo Y, Cockcroft JR, Wilkinson IB: An analysis of prospective risk factors for aortic stiffness in men: 20-year follow-up from the caerphilly prospective study. Hypertension 2010;56:36–43.
22.
Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G: Heart rate-dependence of arterial distensibility in vivo. J Hypertens 1996;14:897–901.
23.
Bolduc V, Drouin A, Gillis MA, Duquette N, Thorin-Trescases N, Frayne-Robillard I, Des Rosiers C, Tardif JC, Thorin E: Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice. Am J Physiol Heart Circ Physiol 2011;301:H2081–2092.
24.
Albaladejo P, Carusi A, Apartian A, Lacolley P, Safar ME, Benetos A: Effect of chronic heart rate reduction with ivabradine on carotid and aortic structure and function in normotensive and hypertensive rats. J Vasc Res 2003;40:320–328.
25.
Dart AM, Kingwell BA: Pulse pressure – a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001;37:975–984.
26.
Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR: Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002;105:213–217.
27.
Wilkinson IB, MacCallum H, Cockcroft JR, Webb DJ: Inhibition of basal nitric oxide synthesis increases aortic augmentation index and pulse wave velocity in vivo. Br J Clin Pharmacol 2002;53:189–192.
28.
Wallace SM, Yasmin, McEniery CM, Maki-Petaja KM, Booth AD, Cockcroft JR, Wilkinson IB: Isolated systolic hypertension is characterized by increased aortic stiffness and endothelial dysfunction. Hypertension 2007;50:228–233.
29.
Ramkhelawon B, Vilar J, Rivas D, Mees B, de Crom R, Tedgui A, Lehoux S: Shear stress regulates angiotensin type 1 receptor expression in endothelial cells. Circ Res 2009;105:869–875.
30.
Stanley AG, Patel H, Knight AL, Williams B: Mechanical strain-induced human vascular matrix synthesis: the role of angiotensin II. J Renin Angiotensin Aldosterone Syst 2000;1:32–35.
31.
Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I: Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. Nat Cell Biol 2004;6:499–506.
32.
Himburg HA, Dowd SE, Friedman MH: Frequency-dependent response of the vascular endothelium to pulsatile shear stress. Am J Physiol Heart Circ Physiol 2007;293:H645–H653.
33.
Lehoux S: Redox signalling in vascular responses to shear and stretch. Cardiovasc Res 2006;71:269–279.
34.
Patel RS, Al Mheid I, Morris AA, Ahmed Y, Kavtaradze N, Ali S, Dabhadkar K, Brigham K, Hooper WC, Alexander RW, Jones DP, Quyyumi AA: Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis 2011;218:90–95.
35.
Lieb W, Larson MG, Benjamin EJ, Yin X, Tofler GH, Selhub J, Jacques PF, Wang TJ, Vita JA, Levy D, Vasan RS, Mitchell GF: Multimarker approach to evaluate correlates of vascular stiffness: the Framingham heart study. Circulation 2009;119:37–43.
36.
Birukov KG: Cyclic stretch, reactive oxygen species, and vascular remodeling. Antioxid Redox Signal 2009;11:1651–1667.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.